Newman Dignan & Sheerar Inc’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,760
Closed -$355K 169
2019
Q1
$355K Buy
+3,760
New +$329K 0.14% 112
2018
Q4
Sell
-3,626
Closed -$316K 155
2018
Q3
$316K Sell
3,626
-40
-1% -$3.54K 0.14% 122
2018
Q2
$291 Sell
3,666
-3,025
-45% -$251K 0.02% 129
2018
Q1
$598K Sell
6,691
-1,015
-13% -$97.4K 0.3% 85
2017
Q4
$804K Sell
7,706
-365
-5% -$41.2K 0.4% 65
2017
Q3
$1.18M Buy
8,071
+300
+4% +$40.9K 0.63% 45
2017
Q2
$1.01M Buy
7,771
+1,265
+19% +$155K 0.56% 53
2017
Q1
$810 Buy
6,506
+565
+10% +$67.6K 0.36% 63
2016
Q4
$688K Sell
5,941
-210
-3% -$23.4K 0.42% 69
2016
Q3
$643K Sell
6,151
-100
-2% -$10.8K 0.4% 69
2016
Q2
$617K Buy
6,251
+2,560
+69% +$265K 0.39% 74
2016
Q1
$369K Buy
3,691
+725
+24% +$74.7K 0.27% 95
2015
Q4
$355K Sell
2,966
-150
-5% -$17.4K 0.25% 100
2015
Q3
$337K Buy
3,116
+450
+17% +$55.8K 0.22% 96
2015
Q2
$309K Buy
2,666
+60
+2% +$6.86K 0.22% 110
2015
Q1
$300K Buy
2,606
+100
+4% +$11.9K 0.21% 112
2014
Q4
$208 Hold
2,506
0.12% 142
2014
Q3
$238K Buy
+2,506
New +$226K 0.18% 125

Other funds holding CELG

Newman Dignan & Sheerar Inc's CELG Position: Q2 2019 in Review

Newman Dignan & Sheerar Inc sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 3,760 shares — an estimated $355K sold.

Newman Dignan & Sheerar Inc first reported a position in CELG in Q3 2014 and held it in 18 quarters. The position peaked at $1.18M in Q3 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Newman Dignan & Sheerar Inc reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Newman Dignan & Sheerar Inc sold 3,760 Celgene Corp shares in Q2 2019, an estimated $355K.
  • Newman Dignan & Sheerar Inc first reported a position in Celgene Corp in Q3 2014 and held it in 18 quarters.
  • Newman Dignan & Sheerar Inc's Celgene Corp position peaked at $1.18M in Q3 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2019, filed 31 Jul 2019.